Table 2 Univariate and multivariate analyses.
Clinicopathologic factors | 5YSR (%) | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | ||
Age (years) | 0.054 | ||||||
≤ 50 | 96.6 | 1.00 | |||||
> 50 | 96.9 | 2.167 | 0.967–4.856 | ||||
Sex | 0.784 | ||||||
Male | 98.0 | 1.00 | |||||
Female | 95.4 | 1.116 | 0.507–2.456 | ||||
Grade | 0.001* | 0.002* | |||||
NET G1 | 96.9 | 1.00 | 1.00 | ||||
NET G2 | 95.2 | 5.719 | 1.793–18.243 | 6.633 | 2.023–21.746 | ||
Size | 0.685 | ||||||
≤ 1 cm | 96.8 | 1.00 | |||||
> 1 cm | 96.2 | 1.354 | 0.311–5.889 | ||||
Proper muscle invasion | 0.232 | ||||||
Absent or NAa | 96.7 | 1.00 | |||||
Present | 75.0 | 3.210 | 0.424–24.296 | ||||
Lymphovascular invasion | 0.029* | 0.492 | |||||
Absent | 97.0 | 1.00 | 1.00 | ||||
Present | 87.5 | 4.455 | 1.027–19.317 | 1.789 | 0.341–9.390 | ||
Perineural invasion | 0.668 | ||||||
Absent | 96.7 | 1.00 | |||||
Present | # | ||||||
Lymph node metastasis | 0.041* | 0.633 | |||||
Absent or NAa | 96.7 | 1.00 | 1.00 | ||||
Present | 50.0 | 6.371 | 0.826–49.136 | 0.542 | 0.044–6.702 | ||
Distant metastasis | < 0.001* | < 0.001* | |||||
Absent | 97.1 | 1.00 | 1.00 | ||||
Present | 0 | 72.812 | 8.132–651.909 | 58.519 | 6.116–559.950 | ||
pT classification | 0.388 | ||||||
pT1 | 96.6 | 1.00 | |||||
pT2–4 | 80.0 | 2.374 | 0.314–17.942 | ||||
AJCC stage group | 0.058 | ||||||
I | 97.0 | 1.00 | |||||
II–IV | 90.9 | 3.775 | 0.862–16.537 | ||||
Chromogranin expression | 0.900 | ||||||
Absent | 96.0 | 1.00 | |||||
Present | 96.3 | 0.934 | 0.320–2.726 | ||||
SSTR2 expression | 0.006* | 0.014* | |||||
Absent | 92.6 | 1.00 | 1.00 | ||||
Present | 98.5 | 0.346 | 0.157–0.759 | 0.365 | 0.164–0.815 |